Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP881564.RASPrkaIKG0OQ-u6laKZsuIigcTTvHulhLMsIJAcTl9ws130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP881564.RASPrkaIKG0OQ-u6laKZsuIigcTTvHulhLMsIJAcTl9ws130_assertion type Assertion NP881564.RASPrkaIKG0OQ-u6laKZsuIigcTTvHulhLMsIJAcTl9ws130_head.
- NP881564.RASPrkaIKG0OQ-u6laKZsuIigcTTvHulhLMsIJAcTl9ws130_assertion wasGeneratedBy ECO_0000203 NP881564.RASPrkaIKG0OQ-u6laKZsuIigcTTvHulhLMsIJAcTl9ws130_provenance.
- NP881564.RASPrkaIKG0OQ-u6laKZsuIigcTTvHulhLMsIJAcTl9ws130_assertion wasDerivedFrom befree-2016 NP881564.RASPrkaIKG0OQ-u6laKZsuIigcTTvHulhLMsIJAcTl9ws130_provenance.
- NP881564.RASPrkaIKG0OQ-u6laKZsuIigcTTvHulhLMsIJAcTl9ws130_assertion SIO_000772 21427164 NP881564.RASPrkaIKG0OQ-u6laKZsuIigcTTvHulhLMsIJAcTl9ws130_provenance.
- NP881564.RASPrkaIKG0OQ-u6laKZsuIigcTTvHulhLMsIJAcTl9ws130_assertion evidence source_evidence_literature NP881564.RASPrkaIKG0OQ-u6laKZsuIigcTTvHulhLMsIJAcTl9ws130_provenance.
- NP881564.RASPrkaIKG0OQ-u6laKZsuIigcTTvHulhLMsIJAcTl9ws130_assertion description "[After subcutaneous administration to mice bearing human prostate cancer PC-3 xenografts, ACA (6 mg/kg/day) remarkably inhibited tumor volume and tumor weight and decreased levels of Src, CD31, VEGF and Ki-67.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP881564.RASPrkaIKG0OQ-u6laKZsuIigcTTvHulhLMsIJAcTl9ws130_provenance.